// App-Quantinova.ai

2933 : Immune System Deregulation Predicts Outcome in Diffuse Large B Cell Lymphoma (DLBCL)

Researchers

Presenter

  • Edward Truelove

Principal Investigators

  • Joseph G Taylor

  • Andrew James Clear

  • Mariarita Calaminici

  • John G. Gribben

Medical Centers

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • Peripheral blood mononuclear cell

  • Lymphocyte count

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved